Table 6 Relative risks of death and hospital admission within 5 years of a cancer diagnosed, 1981–1995, compared to the matched general Scottish population subdivided by tumour type, sex and calendar year of cancer diagnosis

From: Hospital admissions and deaths relating to deliberate self-harm and accidents within 5 years of a cancer diagnosis: a national study in Scotland, UK

 

Death within 5 years of cancer diagnosis, 1981–1995 (95% CIs)

Subgroups

DSH+undetermined

Accidental poisoning

All accidents excluding accidental poisoning

Overall

1.51

1.29–1.76

3.69

2.1–6

1.58

1.48–1.69

Head and neck

1.49

0.53–3.26

6.95

0–39.8

1.67

1.1–2.43

Digestive

1.58

1.12–2.19

1.14

0–6.56

1.56

1.36–1.79

Respiratory

1.71

1.08–2.57

8.03

2.09–20.8

2.44

2.01–2.94

Breast

1.37

0.87–2.07

4.17

0.79–12.3

1.28

1.07–1.53

Female genital

2.52

1.46–4.04

3.30

0–18.9

1.52

1.1–2.06

Prostate

1.33

0.77–2.13

4.59

0.43–16.9

1.12

0.88–1.41

Male genital

1.12

0.29–2.89

—

—

3.39

1.89–5.61

Urinary

1.11

0.63–1.81

3.87

0.36–14.2

1.34

1.07–1.66

Skin

1.16

0.37–2.73

—

—

0.45

0.18–0.94

Lymphoid

1.47

0.8–2.47

—

—

2.42

1.94–2.99

Secondaries/unspec

2.72

0.51–8.04

22.37

0.01–128.2

4.26

2.83–6.16

Other

1.87

0.74–3.87

6.69

0–38.4

1.61

0.92–2.62

Males

1.38

1.12–1.68

4.41

2.19–7.92

1.50

1.35–1.66

Females

1.74

1.36–2.19

2.71

0.85–6.37

1.65

1.5–1.81

Diagnosed 1981–1985

1.40

1.04–1.85

1.76

0.33–5.21

1.59

1.4–1.79

Diagnosed 1986–1990

1.73

1.33–2.22

5.04

2–10.5

1.59

1.41–1.79

Diagnosed 1991–1995

1.41

1.08–1.82

4.82

1.73–10.6

1.56

1.38–1.76

 

Hospital admission within 5 years of cancer diagnosis, 1981–1995 (95% CIs)

Subgroups

DSH+undetermined

Accidental poisoning

All accidents excluding accidental poisoning

Overall

1.04

0.97–1.12

1.32

1.19–1.47

1.19

1.53–1.57

Head and neck

2.03

1.47–2.73

3.74

2.5–5.37

2.29

2.14–2.45

Digestive

1.15

0.95–1.38

1.39

1.07–1.78

1.71

1.66–1.75

Respiratory

1.59

1.28–1.96

2.08

1.53–2.76

1.78

1.71–1.86

Breast

0.93

0.8–1.08

1.05

0.82–1.34

1.26

1.22–1.31

Female genital

1.20

0.99–1.44

1.32

0.93–1.81

1.74

1.66–1.82

Prostate

1.28

0.92–1.74

1.46

0.94–2.16

1.23

1.17–1.29

Male genital

0.63

0.39–0.97

0.82

0.32–1.69

1.16

1–1.34

Urinary

1.02

0.78–1.31

1.26

0.86–1.8

1.33

1.27–1.39

Skin

0.46

0.28–0.7

0.54

0.21–1.12

1.10

1.01–1.2

Lymphoid

0.84

0.64–1.08

0.98

0.62–1.48

1.90

1.81–1.98

Secondaries/unspec

1.53

0.69–2.91

1.68

0.44–4.33

2.01

1.79–2.24

Other

0.78

0.53–1.1

1.22

0.66–2.05

2.16

2–2.33

Males

1.12

1–1.25

1.49

1.26–1.73

1.68

1.65–1.71

Females

1.00

0.91–1.09

1.22

1.05–1.4

1.46

1.43–1.49

Diagnosed 1981–1985

1.24

1.09–1.41

1.41

1.14–1.72

1.56

1.52–1.61

Diagnosed 1986–1990

1.10

0.97–1.25

1.21

0.98–1.47

1.51

1.47–1.54

Diagnosed 1991–1995

0.88

0.79–0.99

1.36

1.16–1.58

1.57

1.54–1.6

Back to article page